ApeX Therapeutics and Researchers at Indiana University to Present Phase 1 Clinical Plan for APX3330 and Novel Approach to ...
INDIANAPOLIS, IN--(Marketwired - May 12, 2016) - ApeX Therapeutics, a biotechnology company focused on developing novel compounds to treat cancer, in collaboration with researchers at Indiana University Simon Cancer Center (IUSCC) today announced two …